19-13081741-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001365902.3(NFIX):c.1140G>A(p.Ser380=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00296 in 1,613,872 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 5 hom. )
Consequence
NFIX
NM_001365902.3 synonymous
NM_001365902.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.233
Genes affected
NFIX (HGNC:7788): (nuclear factor I X) The protein encoded by this gene is a transcription factor that binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3 in viral and cellular promoters. The encoded protein can also stimulate adenovirus replication in vitro. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 19-13081741-G-A is Benign according to our data. Variant chr19-13081741-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 198780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-13081741-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.233 with no splicing effect.
BS2
High AC in GnomAd4 at 356 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFIX | NM_001365902.3 | c.1140G>A | p.Ser380= | synonymous_variant | 8/11 | ENST00000592199.6 | NP_001352831.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFIX | ENST00000592199.6 | c.1140G>A | p.Ser380= | synonymous_variant | 8/11 | 5 | NM_001365902.3 | ENSP00000467512 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00234 AC: 356AN: 152086Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
356
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00228 AC: 568AN: 249118Hom.: 0 AF XY: 0.00222 AC XY: 300AN XY: 135182
GnomAD3 exomes
AF:
AC:
568
AN:
249118
Hom.:
AF XY:
AC XY:
300
AN XY:
135182
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00302 AC: 4417AN: 1461668Hom.: 5 Cov.: 31 AF XY: 0.00298 AC XY: 2169AN XY: 727122
GnomAD4 exome
AF:
AC:
4417
AN:
1461668
Hom.:
Cov.:
31
AF XY:
AC XY:
2169
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00234 AC: 356AN: 152204Hom.: 1 Cov.: 32 AF XY: 0.00226 AC XY: 168AN XY: 74430
GnomAD4 genome
AF:
AC:
356
AN:
152204
Hom.:
Cov.:
32
AF XY:
AC XY:
168
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 07, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 27, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | NFIX: BP4, BP7, BS1 - |
Marshall-Smith syndrome;C3553660:Malan overgrowth syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at